American Association for Cancer Research

AACR/JCA Joint Conference: Breakthroughs in Basic and Translational Cancer Research

AACR-JCA Breakthroughs in Basic and Translational Cancer Research 2013 - Brain-tropic human metastatic breast cancer cells overexpressing pigment epithelium-derived factor rapidly became apoptotic when implanted into a mouse brain. Red, human mitochondria (tumor cells); green, cleaved caspase-3 stain (apoptosis); blue, DAPI. Reprinted from figure 4: Fitzgerald DP, et al. Cancer Res. 2012 Jan 1;72(1):144-53.Ninth AACR-Japanese Cancer Association Joint Conference: Breakthroughs in Basic and Translational Cancer Research
February 21-25, 2013
Hyatt Regency Maui
Maui, HI

CONFERENCE CO-CHAIRPERSONS:
Tyler Jacks, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA (AACR)
Kohei Miyazono, University of Tokyo, Tokyo, Japan (JCA)

More than 20 years ago, the American Association for Cancer Research and the Japanese Cancer Association held their first of eight joint conferences. These meetings have been aimed at bringing outstanding American and Japanese researchers together with two goals - (1) to provide a forum for discussion of the latest advances in basic, translational, and clinical cancer research, and (2) to provide a mechanism for the interpersonal interactions which foster international collaborations. These conferences have been extremely successful in both areas and are tangible examples of the close relationship between the AACR and the JCA.

ORGANIZING COMMITTEE:
Lynda Chin, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (AACR)
Lisa M. Coussens, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA (AACR)
Mari Kannagi, Tokyo Medical & Dental University, Tokyo, Japan (JCA)
Gou Young Koh, Korea Advanced Institute, Daejeon, Korea (Rep.) (JCA)
Sean J. Morrison, UT Southwestern Medical Center, Dallas, TX, USA (AACR)
Hitoshi Nakagama, National Cancer Center Research Institute, Tokyo, Japan (JCA)
Tomoki Naoe, Nagoya University Hospital, Nagoya, Japan (JCA)
Motoharu Seiki, University of Tokyo, Institute of Medical Science, Tokyo, Japan (JCA)
Jeffrey E. Settleman, Genentech Inc., South San Francisco, CA, USA (AACR)
Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA (AACR)


Lead Supporter

Celgene


Major Supporter

Genentech


Supporters

Amgen, Inc.     AntiCancer, Inc.

Chugai Academy for Advanced Oncology     PerkinElmer

Uehara Memorial Foundation 


Award Supporters

Aflac      NCI Center to Reduce Cancer Health Disparities

* Adobe Acrobat Reader required

Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.